Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment
Part of paid clinical trials in San Diego, California.
- Sponsor
- Tools4Patient
- Study ID
- NCT07456930
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to learn whether the Compl-AI model can accurately predict who is likely to stop their medication for opioid use disorder (MOUD) early in adults receiving real-world treatment for opioid use disorder (OUD). The main questions it aims to answer is: can the model accurately predict early discontinuation of MOUD? Because this study has no comparison groups, all participants receive their usual MOUD as part of routine care. Researchers will observe how participants engage with treatment and how well Compl-AI predicts their outcomes. Participants will complete 4 visits, including a questionnaire about personal experiences during first visit and questions about their substance use and treatment history. During the monthly study visits, the researchers will record in particular the attendance at MOUD medication visits, the medication adherence and any treatment discontinuation.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 295 participants (estimated)
Primary Outcome Measure
Proportion of attended MOUD medication visits [ Time Frame: Observation period will be three (3) months. ]
Central Contacts
- Chantal Gossuin+32(0)71140200
- Laura Onckelinx+32(0)71140200
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| SOAP MAT, LLC - Central | San Diego | California | 92115 | |
| SOAP MAT, LLC - Vista | Vista | California | 92083 |
Find similar trials in San Diego, CA
Related Studies
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.PHASE4 · Recruiting · Yale University · Oakland, California
- Standard Versus High Dose ED-Initiated Buprenorphine InductionPHASE3 · Recruiting · Yale University · Oakland, California